Which diagnostic test should be ordered now for a 7-year-old boy with restless sleep, weight loss, hyperactivity, mood changes, developmental delay, and epilepsy controlled with clobazam?

Order a Polysomnogram (PSG) Now

Given this 7-year-old boy with epilepsy, developmental delays, and restless sleep that started after an infection, you should order a polysomnogram (option b) to evaluate for potential sleep-related breathing disorders, nocturnal seizures, and other sleep architecture abnormalities that could be contributing to his symptoms and quality of life.

Clinical Reasoning

Why Polysomnography is the Priority

This child presents with several concerning features that warrant comprehensive sleep evaluation:

• Restless sleep with tossing and turning all night suggests possible sleep fragmentation
• Difficulty waking in the morning despite 12 hours in bed (7 PM to 7 AM) indicates poor sleep quality or pathologic hypersomnia
• Weight loss is a red flag that could indicate increased work of breathing or other metabolic issues
• Hyperactivity and mood changes may reflect sleep deprivation consequences
• Pre-existing epilepsy requires differentiation between nocturnal seizures and primary sleep disorders
• Developmental delays place him in a high-risk population for sleep disorders

The absence of snoring does not exclude sleep-disordered breathing in children with developmental delays and epilepsy. Polysomnography can identify obstructive sleep apnea, central sleep apnea, periodic breathing, and capture nocturnal seizure activity that may be contributing to his symptoms 1.

Why Not the Other Options

Actigraphy (option a): While the 2018 AASM guidelines support actigraphy for pediatric patients with circadian rhythm sleep-wake disorders and specifically note its utility in children with developmental delays 2, this child's presentation does not suggest a circadian disorder. He has a consistent 12-hour sleep opportunity (7 PM-7 AM) with restless, fragmented sleep rather than delayed sleep onset or offset times. Actigraphy would miss sleep-disordered breathing, nocturnal seizures, and sleep architecture abnormalities.

Ambulatory EEG (option c): While this could capture nocturnal seizures, his epilepsy is reportedly controlled on clobazam 3. The constellation of symptoms—particularly the weight loss, difficulty waking, and restless sleep—suggests a primary sleep disorder rather than breakthrough seizures. If PSG captures epileptiform activity, then ambulatory EEG could be considered subsequently.

BTBD9 and MEIS1 testing (option d): These genetic tests are associated with restless legs syndrome. However, this nonverbal child with developmental delays cannot report the characteristic urge to move legs or sensory discomfort. The clinical picture is more consistent with sleep fragmentation from another cause rather than RLS.

Critical Considerations

Clobazam's Role

Clobazam is FDA-approved for Lennox-Gastaut syndrome 3, though this child's diagnosis isn't specified. While clobazam can cause somnolence and sedation 3, his symptoms of hyperactivity and difficulty waking suggest inadequate sleep quality rather than medication over-sedation. The timing (symptoms started 2 years ago after an infection, current medication regimen unclear) requires clarification, but doesn't change the need for objective sleep assessment.

High-Risk Features for PSG Complications

If sleep-disordered breathing is identified, this child has multiple risk factors that would require careful management:

• Developmental delays and epilepsy
• Young age (7 years)
• Decreased tone on exam
• Current benzodiazepine use

These factors increase risk for respiratory complications and would necessitate close monitoring if interventions like adenotonsillectomy were considered 4.

Next Steps After PSG

Based on PSG findings:

• If sleep-disordered breathing is identified: Consider ENT evaluation for adenotonsillar hypertrophy, optimize sleep position, consider CPAP if surgical intervention not feasible
• If nocturnal seizures are captured: Adjust antiepileptic regimen in consultation with neurology
• If sleep architecture is severely disrupted without clear cause: Consider narcolepsy-like phenotype (can occur in neurodevelopmental disorders 5) and evaluate for central hypersomnolence
• If PSG is normal: Then consider actigraphy to assess for circadian rhythm disorders or behavioral sleep issues

The weight loss and fatigue are particularly concerning and suggest this is affecting his overall health and development, making timely diagnosis essential for his quality of life and long-term outcomes 2.